Cargando…

Preserved ejection fraction and structural heart disease in 446 848 patients investigated with echocardiography

BACKGROUND: Sex‐specific differences in left ventricular ejection fraction (LVEF) and responses to neurohormonal modulating therapies are relevant to clinical trials of treatment for heart failure with preserved ejection fraction (HFpEF). AIMS: This study aimed to identify the proportion and charact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Playford, David, Strange, Geoffrey, Stewart, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006609/ https://www.ncbi.nlm.nih.gov/pubmed/33350098 http://dx.doi.org/10.1002/ehf2.13149

Ejemplares similares

Minimal subphenotyping model for acute heart failure with preserved ejection fraction
por: Sotomi, Yohei, et al.
Publicado: (2022)

Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
por: D'Assante, Roberta, et al.
Publicado: (2021)

Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction
por: Tanacli, Radu, et al.
Publicado: (2020)

Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction
por: Erhardsson, Mikael, et al.
Publicado: (2023)

Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction
por: Büttner, Petra, et al.
Publicado: (2022)

The clinical significance of plasma neopterin in heart failure with preserved left ventricular ejection fraction
por: Yamamoto, Eiichiro, et al.
Publicado: (2015)

The effect of exercise training on biventricular myocardial strain in heart failure with preserved ejection fraction
por: Angadi, Siddhartha S., et al.
Publicado: (2017)

Recurrent heart failure with preserved ejection fraction associated with carfilzomib administration for multiple myeloma
por: Yang, Eric H., et al.
Publicado: (2018)

Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction
por: Tamaki, Shunsuke, et al.
Publicado: (2020)

Plasma P‐selectin is a predictor of mortality in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2021)

The value of exercise echocardiography in heart failure with preserved ejection fraction
por: Donal, Erwan
Publicado: (2019)

High Intensity Exercises in Heart Failure with Preserved Ejection Fraction
por: Herdy, Artur Haddad, et al.
Publicado: (2018)

Impaired myocardial relaxation with exercise determines peak aerobic exercise capacity in heart failure with preserved ejection fraction
por: Trankle, Cory, et al.
Publicado: (2017)

Sodium‐glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta‐analysis
por: Pandey, Arjun K., et al.
Publicado: (2022)

Angiotensin-Converting Enzyme Inhibitor Therapy Effects in Patients With Heart Failure With Preserved and Mid-Range Ejection Fraction
por: Safonova, Julia, et al.
Publicado: (2021)

Exercise Stress Echocardiography in the Diagnostic Evaluation of Heart Failure with Preserved Ejection Fraction
por: Harada, Tomonari, et al.
Publicado: (2022)

Association between phonocardiography and echocardiography in heart failure patients with preserved ejection fraction
por: Luo, Hongxing, et al.
Publicado: (2022)

Associations between acylcarnitine to free carnitine ratio and adverse prognosis in heart failure patients with reduced or preserved ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2017)

Exercise echocardiography in aortic stenosis with preserved ejection fraction
por: Postolache, Adriana, et al.
Publicado: (2020)

Incident pulmonary hypertension in 13 488 cases investigated with repeat echocardiography: a clinical cohort study
por: Stewart, Simon, et al.
Publicado: (2023)

Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT
por: Peters, Anthony E., et al.
Publicado: (2021)

Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction
por: Sebastião, Maria J., et al.
Publicado: (2022)

Ergospirometry and Echocardiography in Early Stage of Heart Failure with Preserved Ejection Fraction and in Healthy Individuals
por: Garcia, Eduardo Lima, et al.
Publicado: (2015)

Clinical Usefulness of Speckle-Tracking Echocardiography in Patients with Heart Failure with Preserved Ejection Fraction
por: Lin, Yixia, et al.
Publicado: (2023)

Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
por: Buckley, Leo F., et al.
Publicado: (2018)

Development of heart failure with preserved ejection fraction is independent of eosinophils in a preclinical model
por: Pan, Qi, et al.
Publicado: (2023)

Real‐world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
por: Oh, Jaewon, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Immunocompromised patients: Review of the most common infections happened in 446 hospitalized patients
por: Meidani, Mohsen, et al.
Publicado: (2014)

Deep learning detects heart failure with preserved ejection fraction using a baseline electrocardiogram
por: Unterhuber, Matthias, et al.
Publicado: (2021)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Out with the Old and In with the New: Primary Care Management of Heart Failure with Preserved Ejection Fraction
por: Stewart, Simon, et al.
Publicado: (2022)

Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease
por: Lee, Seonhwa, et al.
Publicado: (2020)

Relative contribution of risk factors/co‐morbidities to heart failure pathogenesis: interaction with ejection fraction
por: Giamouzis, Grigorios, et al.
Publicado: (2020)

Sex‐specific bimodal clustering of left ventricular ejection fraction in patients with acute heart failure
por: Henneges, Carsten, et al.
Publicado: (2021)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_so0bfbgjvmm465u9k46t021g53